Task: Answer the multiple choice question.
Question: Which drug exhibits a 10.315\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CC1=C(C(=O)N2CCOCC2)C(c2ccccc2F)NC(=O)N1
b: COc1cccc(CN2CCNC(=O)C2CC(=O)NCCN2CCOCC2)c1OC
Answer: a. CC1=C(C(=O)N2CCOCC2)C(c2ccccc2F)NC(=O)N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1=C(C(=O)N2CCOCC2)C(c2ccccc2F)NC(=O)N1
CC1=C(C(=O)N2CCOCC2)C(c2ccccc2F)NC(=O)N1
4-(2-fluorophenyl)-6-methyl-5-(morpholine-4-carbonyl)-3,4-dihydro-1H-pyrimidin-2-one